Awesome! Propranolol, an anti-hypertensive drug, prevents the recurrence and death of the malignant melanoma

In a propective study, it was found that after 3 years of treatment with propranolol a big difference in the disease progression. It was observed a recurrence of 41.2% of the patients in the untreated cohort compared with only 15.8% in the propranolol cohort.

Find more information in the link

http://jamanetwork.com/journals/jamaoncology/fullarticle/2655005

.